Crimson Publishers- Novel Approaches in Cancer Study

Lu-177 Dotatate External Dosimetry- An Update from 2013 by Mushref Algarni in Novel Approaches in Cancer Study https://crimsonpublishers.com/nacs/fulltext/NACS.000508.php London health sciences center is a frequent user of Lu-177 Dotatate for the treatment of neuroendocrine disease. We began using this radionuclide therapy as an in-patient procedure, where patients were released at 20 hours’ post therapy administration with minimal restrictions. Over the course of 2013, we worked to transform this therapy into an outpatient procedure, where patients were released at 4-6 hours’ post therapy administration with major restrictions. For more Open access journals in Crimson Publishers Please click on: https://crimsonpublishers.com/ For more articles in Open access journal of Novel Approaches in Cancer Study Please click on: https://crimsonpublishers.com/nacs/index.php

Cancer, Quantum Computing and TP53 Tumor Suppressor Gene Mutations Prediction by Jean-claude Perez in Novel Approaches in Cancer Study https://crimsonpublishers.com/nacs/fulltext/NACS.000507.php Crimson Publishers_NACS Mutations in the TP53 gene are encountered in about one in every two cases of cancer. The locations and frequencies of these mutations are well known and listed. It is therefore on these mutations of TP53 that we validate here a theoretical method of prediction of the mutagenic regions of TP53. This method uses the Master Code of Biology, revealing a coupling and unification between the Genomics and Proteomics codes for any DNA sequence analyzed. For more Open access journals in Crimson Publishers Please click on: https://crimsonpublishers.com/ For more articles in Open access journal of Novel Approaches in Cancer Study Please click on: https://crimsonpublishers.com/nacs/index.php